Navigation Links
Tumor Resistant Mice Point To Novel Cancer Treatments

Researchers have established that white blood cells, derived from immune mice, have an innate immunity against cancer, which can be exploited// in the development of novel forms of cancer treatment. When such cells were introduced into other mice with cancer, it was found to confer a lifelong immunity against the much-dreaded disease.

This study for the first time highlights the presence of a biological pathway in a specific species. Previous studies had suggested a similar link in humans as well, that could be harnessed to arrive at a novel approach for cancer treatment.

‘The idea of cells being able to kill tumor cells ... is very exciting. But this is a mouse, and there is no guarantee that the same gene will exist in people,’ said biologist Howard Young of the National Cancer Institute's Center for Cancer Research.

’This is a truly remarkable phenomenon ... and it really needs confirmation from other institutions," said Dr. Zhen Cui of Wake Forest. The limited availability of these special mice ensures that the above results have not been reported by any another lab or research organisation. The results of this interesting study have been published in the Proceedings of the National Academy of Science.

The researchers are said to have ended up with the remarkable immune mice by accident, in the year 1999. The researchers initial studies were targeted at identifying biological mechanisms behind the spread of cancer.

As a part of this study, highly virulent cancer cells were introduced into mice. Surprisingly, one of the mice injected with cancer cells had not developed any tumor. This effect was seen even when the animal was injected with tumor cells, approximating to 10% of its body weight.

Out of curiosity, the researchers bread the mouse, only to find that 50% of its offspring had the same kind of tumor resistance. Cross breeding experiments were also taken up. The researchers upon analysis found that white blood cells of the tumor resistant mice induced a killing process called cytolysis. A combination of WBCs (neutrophils, macrophages and natural killer cells) from the special mice was then injected into mice with tumors.

As expected, these injected cells were found to destroy the tumor, even the most aggressive forms. More importantly the healthy tissue was unaffected and normal mice with tumors developed a life long immunity against tumors.

‘This is the first report of a novel [treatment] mechanism. The two most dramatic things are: one, that the response itself is outstanding, and two, the fact that they looked at a variety of different cell lines and found the activity was there for all of them, said Dr. Andrew Raubitschek, a cancer immunologist at the City of Hope National Medical Center in Duarte.

‘This deserves intensive follow-up. Cui's papers are technically sound, carefully controlled and well thought out. But whenever there is a result this surprising, it's always important to have others confirm it,’ concluded Dr. Richard Miller of the University of Michigan Medical School.
br>
'"/>




Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Radiofrequency Energy Cooks Tumors Without Surgery
3. New Liver Tumor Treatment
4. Latest Tumor Classification More Informative
5. New Technique For Benign Breast Tumors
6. Another Treatment Option for Benign Tumors
7. Understanding The Origin Of Tumors
8. Outpatient Treatment Possible For Patients with Uterine Fibroid Tumors
9. Stem Cells, Tumor Cells Share Similar Properties: Scope For Treatment and Prevention?
10. Lipoma Arborescens: A Rare Tumor Of The Knee
11. Researchers Develop Mouse Model Of Brain Tumor
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Those who ... with these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, ... Marne, Michigan, has released tools for healthy coping following a traumatic event. , Trauma ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
Breaking Medicine Technology: